Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1241-1246

  Gnanasekar, Munirathinam ^a   Thirugnanam, Sivasakthivel ^a   Zheng, Guoxing ^a   Chen, Aoshuang ^a   Ramaswamy, Kalyanasundaram ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

LNCaP; Prostate cancer; siRNA; Translationally controlled tumor protein

Indexed keywords

CASPASE 3; CASPASE 8; LIPOCORTIN 5; MESSENGER RNA; ONCOPROTEIN; SMALL INTERFERING RNA; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CASPASE 3; CASPASE 8; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 67649449949     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000252     Document Type: Article

References (40)

1. Bohm H, Benndorf R, Gaestel M, Gross B, Nurnberg P, Kraft R, Otto A and Bielka H: The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure. Biochem Int 19: 277-286, 1989.
2. Bonnet C, Perret E, Dumont X, Picard A, Caput D and Lenaers G: Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest. Yeast 16: 23-33, 2000.
3. MacDonald SM, Rafnar T, Langdon J and Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 269: 688-690, 1995.
4. Li F, Zhang D and Fujise K: Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 276: 47542-47549, 2001.
5. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R and Telerman A: Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99: 14976-14981, 2002.
6. Arcuri F, Papa S, Carducci A, Romagnoli R, Liberatori S, Riparbelli MG, Sanchez JC, Tosi P and del Vecchio MT: Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity. Prostate 60: 130-140, 2004.
7. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Geant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J, Moras D, Amson R and Telerman A: Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 101: 15364-15369, 2004.
8. Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K, Mukai K and Kuroda M: Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem Biophys Res Commun 290: 984-987, 2002.
9. Sturzenbaum SR, Kille P and Morgan AJ: Identification of heavy metal induced changes in the expression patterns of the translationally controlled tumour protein (TCTP) in the earthworm Lumbricus rubellus1. Biochim Biophys Acta 1398: 294-304, 1998.
10. Vercoutter-Edouart AS, Czeszak X, Crepin M, Lemoine J, Boilly B, Le Bourhis X, Peyrat JP and Hondermarck H: Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262: 59-68, 2001.
11. Baudet C, Perret E, Delpech B, Kaghad M, Brachet P, Wion D and Caput D: Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program. Cell Death Differ 5: 116-125, 1998.
12. Gnanasekar M, Rao KV, Chen L, Narayanan RB, Geetha M, Scott AL, Ramaswamy K and Kaliraj P: Molecular characterization of a calcium binding translationally controlled tumor protein homologue from the filarial parasites Brugia malayi and Wuchereria bancrofti. Mol Biochem Parasitol 121: 107-118, 2002.
13. Rao KV, Chen L, Gnanasekar M and Ramaswamy K: Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J Biol Chem 277: 31207-31213, 2002.
14. Yarm FR: Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol 22: 6209-6221, 2002.
15. Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T and Bommer UA: The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci 112: 1257-1271, 1999.
16. Saleem M, Adhami VM, Ahmad N, Gupta S and Mukhtar H: Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res 11: 147-153, 2005.
17. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V and Mukhtar H: S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 103: 14825-14830, 2006.
18. Zhu N and Wang Z: Calreticulin expression is associated with androgen regulation of the sensitivity to calcium ionophore-induced apoptosis in LNCaP prostate cancer cells. Cancer Res 59: 1896-1902, 1999.
19. Furuya Y, Lundmo P, Short AD, Gill DL and Isaacs JT: The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167-6175, 1994.
20. McConkey DJ and Orrenius S: The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239: 357-366, 1997.
21. Taulli R, Accornero P, Follenzi A, Mangano T, Morotti A, Scuoppo C, Forni PE, Bersani F, Crepaldi T, Chiarle R, Naldini L and Ponzetto C: RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis. Cancer Gene Ther 12: 456-463, 2005.
22. Yang Q, Fung KM, Day WV, Kropp BP and Lin HK: Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival. Cancer Cell Int 5: 8, 2005.
23. Zhang D, Li F, Weidner D, Mnjoyan ZH and Fujise K: Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone. J Biol Chem 277: 37430-37438, 2002.
24. Yuan XJ and Whang YE: PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 21: 319-327, 2002.
25. Bommer UA and Thiele BJ: The translationally controlled tumour protein (TCTP). Int J Biochem Cell Biol 36: 379-385, 2004.
26. Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N, Allanic D, Tufino R, Argentini M, Moras D, Fiucci G, Goud B, Mirande M, Amson R and Telerman A: Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc Natl Acad Sci USA 100: 13892-13897, 2003.
27. Kozielski F, Skoufias DA, Indorato RL, Saoudi Y, Jungblut PR, Hustoft HK, Strozynski M and Thiede B: Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5. Proteomics 8: 289-300, 2008.
28. Jankun J, Aleem AM, Specht Z, Keck RW, Lysiak-Szydlowska W, Selman SH and Skrzypczak-Jankun E: PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells. Int J Mol Med 20: 11-20, 2007.
29. Zhu WL, Cheng HX, Han N, Liu DL, Zhu WX, Fan BL and Duan FL: Messenger RNA expression of translationally controlled tumor protein (TCTP) in liver regeneration and cancer. Anticancer Res 28: 1575-1580, 2008.
30. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY and Yang-Yen HF: A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell 18: 2525-2532, 2007.
31. Liu Z, Bengtsson S, Krogh M, Marquez M, Nilsson S, James P, Aliaya A and Holmberg AR: Somatostatin effects on the proteome of the LNCaP cell-line. Int J Oncol 30: 1173-1179, 2007.
32. Burgess A, Labbe JC, Vigneron S, Bonneaud N, Strub JM, van Dorsselaer A, Lorca T and Castro A: Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene (In press).
33. Thorburn A: Death receptor-induced cell killing. Cell Signal 16: 139-144, 2004.
34. Qi W, Wu H, Yang L, Boyd DD and Wang Z: A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. EMBO J 26: 65-75, 2007.
35. Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine JC, Martinou JC, Cavarelli J, Moras D, Amson R and Telerman A: TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 15: 1211-1220, 2008.
36. Lee DH, Szczepanski M and Lee YJ: Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem Pharmacol 75: 2345-2355, 2008.
37. Mitterberger M, Neuwirt H, Cavarretta IT, Hobisch A and Culig Z: Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide. Prostate 67: 1194-1201, 2007.
38. Munshi A, McDonnell TJ and Meyn RE: Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 50: 46-52, 2002.
39. Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA and Cohen MB: Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate 52: 1-11, 2002.
40. 2+-dependent apoptosis in vivo. Biochem J 408: 181-191, 2007.